RSS

CBDL CBD Life Sciences Inc.

Mod: megan Asst: Bklynboy56
Last Post: 07/07/26
Followers: 15
Posts Today: 0
Views Today: 686

CBDL Stock Quote & Tools

$0.0002 ▼ -0.0001 (-25.00%) As of Sep 16, 2:51 PM EDT
Last0.0002
$ Chg-0.0001
Open0.0002
High0.0002
Beta80.5042
Year High0.001
Market Cap683.4K
P/B Ratio
EPS
Avg Vol (30d)1.81M
Volume239.2K
% Chg-25.00%
Prev Close0.0002
Low0.0001
VWAP0.00014
Year Low0.000
Total Shares4.56B
Shares Out4.56B
Float141.69M
ExchangeOTCID
Healthcare Pharmaceuticals

CBDL Stock Message Board Discussion

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

NeuroPace, Inc. Faces Investigation Over Alleged Fraud Claims

Updated Category News Views 146

Investigation of NeuroPace, Inc. NeuroPace, Inc., known for its innovations in medical technology, is currently under scrutiny as claims emerge regarding possible misconduct by its executives. These allegations primarily revolve around securities fraud and other business practices that have raised concerns among investors. Potential Securities Fraud The investigation...

Continue Reading
Dodge Charger Daytona: Power and Innovation Earn Awards

Updated Category News Views 245

Dodge Charger Daytona's Groundbreaking Recognition The Dodge Charger Daytona stood out as a prime example of automotive innovation by earning the admiration of experts and enthusiasts alike. This remarkable vehicle has earned a prestigious accolade, listed among the 2025 Wards 10 Best Engines & Propulsion Systems. This recognition speaks volumes about its unprecedented...

Continue Reading
Understanding Riksbank Certificates: Key Details and Insights

Updated Category News Views 157

Exploring the Riksbank Certificates: A Comprehensive Overview Riksbank certificates play a critical role in the financial market, serving as a vital instrument for liquidity management. Understanding the conditions surrounding these certificates can significantly benefit potential investors and financial institutions alike. Key Dates for Bidding and Settlement When...

Continue Reading
Akebia Therapeutics' New Stock Offering Aims for Growth

Updated Category News Views 169

Akebia Unveils New Public Offering of Common Stock Akebia Therapeutics, Inc. (Nasdaq: AKBA), a dedicated biopharmaceutical company focused on improving the lives of individuals affected by kidney disease, has publicly announced the pricing details of its recent offering. This offering involves 25 million shares of common stock, each priced at $2.00, aiming to generate...

Continue Reading
Exciting Developments at Modera Lady Bird: A New Community

Updated Category News Views 384

New Beginnings at Modera Lady Bird Mill Creek Residential has exciting news as construction kicks off for Modera Lady Bird, a vibrant mixed-use community designed to elevate the living experience with 234 rental homes. This development is poised to make a significant impact in the Northwest quadrant of Washington, D.C. Setting a New Standard for Community Living Breaking...

Continue Reading